EFFECT OF A NOVEL HYPOCHOLESTEROLEMIC AGENT, TRANS-1,4-BIS-(2-CHLOROBENZYLAMINOMETHYL)CYCLOHEXANE DIHYDROCHLORIDE (AY-9944) ON ADRENAL MORPHOLOGY.
D000311:Adrenal Glands; D000818:Animals; D000924:Anticholesteremic Agents; D000963:Antimetabolites; D001717:Birds; D002784:Cholesterol / Q000097:blood*; D003510:Cyclohexanes; D004285:Dogs; D006168:Guinea Pigs; D000882:Haplorhini; D006728:Hormones; D006984:Hypertrophy; D010600:Pharmacology; D051381:Rats; D012106:Research; D013552:Swine; D001371:trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride
D000924:Anticholesteremic Agents; D000963:Antimetabolites; D003510:Cyclohexanes; D006728:Hormones; D001371:trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride; C506365:Cyclohexane; D002784:Cholesterol
ADRENAL GLANDS; ANTICHOLESTEREMIC AGENTS; ANTIMETABOLITES; BIRDS; BLOOD CHOLESTEROL; DOGS; EXPERIMENTAL LAB STUDY; GUINEA PIGS; HORMONES; HYPERTROPHY; MONKEYS; PHARMACOLOGY; RATS; SWINE